RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/15685448http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/15685448http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/15685448http://www.w3.org/2000/01/rdf-schema#comment"Expression of an interferon inducible gene 6-16, G1P3, increases not only in type I interferon-treated cells but also in human senescent fibroblasts. However, the function of 6-16 protein is unknown. Here we report that 6-16 is 34 kDa glycosylated protein and localized at mitochondria. Interestingly, 6-16 is expressed at high levels in gastric cancer cell lines and tissues. One of exceptional gastric cancer cell line, TMK-1, which do not express detectable 6-16, is sensitive to apoptosis induced by cycloheximide (CHX), 5-fluorouracil (5-FU) and serum-deprivation. Ectopic expression of 6-16 gene restored the induction of apoptosis and inhibited caspase-3 activity in TMK-1 cells. Thus 6-16 protein has anti-apoptotic function through inhibiting caspas-3. This anti-apoptotic function is expressed through inhibition of the depolarization of mitochondrial membrane potential and release of cytochrome c. By two-hybrid screening, we found that 6-16 protein interacts with calcium and integrin binding protein, CIB/KIP/Calmyrin (CIB), which interacts with presenilin 2, a protein involved in Alzheimer's disease. These protein interactions possibly play a pivotal role in the regulation of apoptosis, for which further detailed analyses are need. These results overall indicate that 6-16 protein may have function as a cell survival protein by inhibiting mitochondrial-mediated apoptosis."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.org/dc/terms/identifier"doi:10.1007/s00262-004-0645-2"xsd:string
http://purl.uniprot.org/citations/15685448http://purl.org/dc/terms/identifier"doi:10.1007/s00262-004-0645-2"xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Ishihara H."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Ishihara H."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Barrett J.C."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Barrett J.C."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Yamazaki R."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Yamazaki R."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Takeda Y."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Takeda Y."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Naka K."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Naka K."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Ide T."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Ide T."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Matsuzaki T."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Matsuzaki T."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Tahara E."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Tahara E."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Kanno M."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Kanno M."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Tahara H."xsd:string
http://purl.uniprot.org/citations/15685448http://purl.uniprot.org/core/author"Tahara H."xsd:string